Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2,578 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Widdrol induces apoptosis via activation of AMP-activated protein kinase in colon cancer cells.
Kang MR, Park SK, Lee CW, Cho IJ, Jo YN, Yang JW, Kim JA, Yun J, Lee KH, Kwon HJ, Kim BW, Lee K, Kang JS, Kim HM. Kang MR, et al. Oncol Rep. 2012 May;27(5):1407-12. doi: 10.3892/or.2012.1644. Epub 2012 Jan 19. Oncol Rep. 2012. PMID: 22266984
A novel approach to cancer therapy using PX-478 as a HIF-1α inhibitor.
Lee K, Kim HM. Lee K, et al. Arch Pharm Res. 2011 Oct;34(10):1583-5. doi: 10.1007/s12272-011-1021-3. Arch Pharm Res. 2011. PMID: 22076756 Review.
Sulfiredoxin inhibitor induces preferential death of cancer cells through reactive oxygen species-mediated mitochondrial damage.
Kim H, Lee GR, Kim J, Baek JY, Jo YJ, Hong SE, Kim SH, Lee J, Lee HI, Park SK, Kim HM, Lee HJ, Chang TS, Rhee SG, Lee JS, Jeong W. Kim H, et al. Free Radic Biol Med. 2016 Feb;91:264-74. doi: 10.1016/j.freeradbiomed.2015.12.023. Epub 2015 Dec 23. Free Radic Biol Med. 2016. PMID: 26721593
Artemisinin inhibits lipopolysaccharide-induced interferon-β production in RAW 264.7 cells: implications on signal transducer and activator of transcription-1 signaling and nitric oxide production.
Park KH, Yoon YD, Han SB, Oh SJ, Yun J, Lee CW, Lee K, Park SK, Kim HM, Kang JS. Park KH, et al. Int Immunopharmacol. 2012 Dec;14(4):580-4. doi: 10.1016/j.intimp.2012.09.012. Epub 2012 Oct 2. Int Immunopharmacol. 2012. PMID: 23041519
2,578 results
Jump to page